GlassScriptPhysician profile
Timothy Trotter
NPI 1285602532
$485.43
in general payments reported to CMS, 2019-2025
12 companies · $20.11 in 2025
The $20.11 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.16 · 2020: $87.35 · 2022: $29.52 · 2023: $264 · 2024: $33.32 · 2025: $20.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $108.13 | 2020-2025 | Giapreza |
| Surmodics, INC. | $84.51 | 2023-2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Hemosonics LLC | $76.03 | 2023 | Quantra Qplus System |
| Zimmer Biomet Holdings, INC. | $60.74 | 2023 | |
| Baxter Healthcare | $32.69 | 2023 | Preveleak |
| Chiesi USA, INC. | $25.26 | 2019 | |
| Lemaitre Vascular, INC. | $22.92 | 2023 | Artegraft Vascular Graft, Cardiocel |
| Abbott Laboratories | $21.80 | 2020 | |
| Medtronic USA, INC. | $16.55 | 2020 | |
| Smith+Nephew, INC. | $15.45 | 2019 | |
| Kls-Martin L.P. | $10.90 | 2022 | |
| Biomerieux INC | $10.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Trotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.